Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
United States paid the most for ivermectin in Q2 2026: USD 448.00/KG, up 3.0% from USD 435.00 in Q1.
Ivermectin is a macrocyclic lactone produced by fermenting Streptomyces avermitilis to yield avermectin, then hydrogenating the fermentation product to reach the final active ingredient. It is one of the most widely used antiparasitic compounds in both human and veterinary medicine worldwide.
Veterinary demand, particularly livestock deworming formulations for cattle, sheep, and swine, accounts for the majority of global volume, with human formulations for conditions like river blindness and scabies representing a smaller but steady secondary market.
India and China host the bulk of global bulk API fermentation and hydrogenation capacity, giving both countries a structural cost advantage over Western manufacturers who typically import intermediate or finished API for formulation.
A buyer choosing between Brazil and United States in Q2 2026 faced a price gap of roughly 25%, the widest split among the regions in this report. Local production economics and import exposure explain most of that difference.
Expect steady gains across all four markets through H2 2026 as veterinary demand continues its seasonal build into deworming season.
India and China should retain their cost advantage given established fermentation infrastructure, though the gap to Western markets should narrow modestly.
Any disruption to fermentation feedstock supply chains would be the key risk to watch given the specialised nature of avermectin production.
H1 2026 closed with the 4 tracked markets averaging a 4.2% increase move quarter on quarter. That trajectory should hold into H2 unless one of the cost or demand drivers above shifts materially.
| Region | 2026 Price Range (USD/KG) | Outlook |
| Global Average | 384.60 - 424.26 | Balance of regional supply and demand conditions |
| India | 370.54 - 408.74 | Seasonal livestock deworming demand built through the quarter |
| China | 386.06 - 425.86 | Strong export demand alongside firm domestic veterinary use kept China's pricing rising in step with the broader market |
| United States | 434.56 - 479.36 | Formulators continued sourcing API from lower-cost Asian producers |
| Brazil | 347.26 - 383.06 | Growing domestic livestock demand supported another incremental gain |
India's price gained 4.7% to USD 382.00/KG, seasonal livestock deworming demand built through the quarter supporting, making it the 3rd most expensive of the 4 markets tracked here this quarter.
Why did the price of Ivermectin change in Q2 2026 in India?
Seasonal livestock deworming demand built through the quarter, supporting a firm increase from the region's established API base, which puts India roughly 3.7% below the average across the 4 regions this report tracks.
In Q2 2026, China priced at USD 398.00/KG, up 4.7% from USD 380.00/KG the previous quarter, ranking it the 2nd most expensive among the 4 markets this report follows.
Why did the price of Ivermectin change in Q2 2026 in China?
Strong export demand alongside firm domestic veterinary use kept China's pricing rising in step with the broader market, working out to China trading about 0.4% above this quarter's 4-region average.
United States reached USD 448.00/KG in Q2 2026, formulators continued sourcing API from lower-cost Asian producers and, placing it the priciest across the 4 regions covered in this report.
Why did the price of Ivermectin change in Q2 2026 in United States?
Formulators continued sourcing API from lower-cost Asian producers, and modest cost pass-through kept US pricing at the top of the group, leaving United States running roughly 13.0% above the 4-region average for the quarter.
Brazil rose 4.7% to USD 358.00/KG in Q2 2026, growing domestic livestock demand supported another incremental gain though, putting it the most affordable of the 4 markets tracked this quarter.
Why did the price of Ivermectin change in Q2 2026 in Brazil?
Growing domestic livestock demand supported another incremental gain, though Brazil remained the most competitively priced market, with Brazil now sitting about 9.7% below the 4-region average this quarter.
India's price gained 1.8% to USD 365.00/KG, early-year restocking ahead of the deworming season supported a, making it the 3rd most expensive of the 4 markets tracked here this quarter.
Why did the price of Ivermectin change in Q1 2026 in India?
Early-year restocking ahead of the deworming season supported a firm start to 2026, which puts India roughly 4.1% below the average across the 4 regions this report tracks.
In Q1 2026, China priced at USD 380.00/KG, up 1.7% from USD 373.59/KG the previous quarter, ranking it the 2nd most expensive among the 4 markets this report follows.
Why did the price of Ivermectin change in Q1 2026 in China?
Steady fermentation capacity utilisation carried prices modestly higher as the year began, working out to China trading about 0.1% below this quarter's 4-region average.
United States reached USD 435.00/KG in Q1 2026, formulator demand held steady tracking the broader upward trend, placing it the priciest across the 4 regions covered in this report.
Why did the price of Ivermectin change in Q1 2026 in United States?
Formulator demand held steady, tracking the broader upward trend from Asian API sourcing, leaving United States running roughly 14.3% above the 4-region average for the quarter.
Brazil rose 1.7% to USD 342.00/KG in Q1 2026, growing domestic veterinary demand supported a modest early-year increase, putting it the most affordable of the 4 markets tracked this quarter.
Why did the price of Ivermectin change in Q1 2026 in Brazil?
Growing domestic veterinary demand supported a modest early-year increase, with Brazil now sitting about 10.1% below the 4-region average this quarter.
The global average climbed steadily across the window, from USD 356.25/KG in Q1 2025 to USD 396.50 by Q2 2026, a gain of 11.3% over six quarters.
| Quarter | Price (USD/KG) | QoQ Change | Direction |
| Q2 2026 | 396.50 | +4.2% | ↑ Rising |
| Q1 2026 | 380.50 | +1.7% | ↑ Rising |
| Q4 2025 | 374.29 | +1.7% | ↑ Rising |
| Q3 2025 | 368.17 | +1.7% | ↑ Rising |
| Q2 2025 | 362.16 | +1.7% | ↑ Rising |
| Q1 2025 | 356.25 | - | - Stable |
| Q3 2026 | In Progress | - | - In Progress |
Ivermectin pricing trended upward through 2025 on a global average basis, starting the year around USD 356.25/KG and ending it at USD 374.29, a 5.1% increase over the four quarters.
India prices moved from about USD 340.00/KG in Q1 2025 to USD 358.58 by Q4, up roughly 5.5%, placing India 3 of 4 tracked markets as 2025 closed out.
China prices moved from about USD 355.00/KG in Q1 2025 to USD 373.59 by Q4, up roughly 5.2%. China closed the year ranked 2 of the 4 markets this report tracks.
United States prices moved from about USD 410.00/KG in Q1 2025 to USD 428.61 by Q4, up roughly 4.5%, leaving United States in 1 place among the 4 tracked markets heading into the new year.
Brazil prices moved from about USD 320.00/KG in Q1 2025 to USD 336.36 by Q4, up roughly 5.1%. That left Brazil ranked 4 of 4 tracked markets heading into 2026.
Expert Market Research: Your Source for Real-Time Ivermectin Price Intelligence
Rather than reporting a single number in isolation, we follow ivermectin pricing back to its roots: avermectin B1 (fermentation) and hydrogen costs, regional supply and demand balance, and the policy shifts that move both. That research gets updated on an ongoing basis across every region we cover.
Forecasts draw on production capacity data, feedstock cost trends, and demand signals from the regions we track, giving procurement and sourcing teams a grounded basis for budgeting and supplier negotiations rather than a single static number.
For a deeper regional cut, historical data beyond the six quarters covered here, or a sourcing analysis tailored to your own procurement footprint, get in touch with our analyst team directly.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Ivermectin is a macrocyclic lactone produced by fermenting Streptomyces avermitilis to yield avermectin, then hydrogenating the fermentation product to reach the final active ingredient. It is one of the most widely used antiparasitic compounds in both human and veterinary medicine worldwide.
In Q2 2026, it averaged USD 382.00/KG in India, USD 398.00/KG in China, USD 448.00/KG in United States, USD 358.00/KG in Brazil, with United States the priciest of the 4 markets tracked in this report.
The global average moved from USD 374.29/KG in Q4 2025 to USD 380.50 in Q1 2026, then to USD 396.50 by Q2, a 5.9% increase across the two quarters.
Seasonal livestock deworming demand built through the quarter supporting a firm increase from the region's established api base, a pattern echoed with local variation across the other markets this report follows.
Expect steady gains across all four markets through H2 2026 as veterinary demand continues its seasonal build into deworming season.
Among the 4 regions this report covers, United States trades highest and Brazil trades lowest, a gap driven by differences in local production cost, import exposure, and demand intensity rather than any single factor.
Livestock deworming demand, the largest single end use by volume; Fermentation and hydrogenation capacity utilisation across major Indian and Chinese producers; Human antiparasitic treatment demand, a smaller but steady secondary market, along with broader macroeconomic conditions across the 4 regions this report tracks.
Ivermectin is a macrocyclic lactone produced by fermenting Streptomyces avermitilis to yield avermectin, then hydrogenating the fermentation product to reach the final active ingredient. It is one of the most widely used antiparasitic compounds in both human and veterinary medicine worldwide.
This report tracks bulk API pricing, which feeds both veterinary and human finished formulations. Veterinary products use the API in much larger relative volumes at lower per-dose regulatory requirements, while human formulations require more extensive quality documentation, which affects the finished product price far more than it affects the underlying bulk API tracked here.
Monthly, though our analysts flag any material shift in feedstock costs or regional demand as soon as it emerges.
One Year Subscription
One Year Subscription
USD 799
USD 699
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.